Page last updated: 2024-11-08

pentylenetetrazole and Acute Liver Injury, Drug-Induced

pentylenetetrazole has been researched along with Acute Liver Injury, Drug-Induced in 5 studies

Pentylenetetrazole: A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility.
pentetrazol : An organic heterobicyclic compound that is 1H-tetrazole in which the hydrogens at positions 1 and 5 are replaced by a pentane-1,5-diyl group. A central and respiratory stimulant, it was formerly used for the treatment of cough and other respiratory tract disorders, cardiovascular disorders including hypotension, and pruritis.

Research Excerpts

ExcerptRelevanceReference
"The activity of these compounds on seizure control is independent of histone deacetylase inhibitory activity (associated with the teratogenicity of VPA), and does not correlate with liver cell toxicity."1.39Seizure control by ketogenic diet-associated medium chain fatty acids. ( Chang, P; Chen, PE; Plant, N; Terbach, N; Walker, MC; Williams, RS, 2013)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Warner, DJ1
Chen, H1
Cantin, LD1
Kenna, JG1
Stahl, S1
Walker, CL1
Noeske, T1
Abdel-Dayem, MA1
Elmarakby, AA1
Abdel-Aziz, AA1
Pye, C1
Said, SA2
El-Mowafy, AM1
El-Agamy, DS1
Chang, P1
Terbach, N1
Plant, N1
Chen, PE1
Walker, MC1
Williams, RS1
FISCHER, A1
TAKACS, L1
VARGA, I1

Other Studies

5 other studies available for pentylenetetrazole and Acute Liver Injury, Drug-Induced

ArticleYear
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters

2012
Valproate-induced liver injury: modulation by the omega-3 fatty acid DHA proposes a novel anticonvulsant regimen.
    Drugs in R&D, 2014, Volume: 14, Issue:2

    Topics: Administration, Oral; Animals; Anticonvulsants; Chemical and Drug Induced Liver Injury; Docosahexaen

2014
Prevention of sodium valproate-induced hepatotoxicity by curcumin, rosiglitazone and N-acetylcysteine in rats.
    Arzneimittel-Forschung, 2010, Volume: 60, Issue:11

    Topics: Acetylcysteine; Animals; Anticonvulsants; Body Weight; Chemical and Drug Induced Liver Injury; Convu

2010
Seizure control by ketogenic diet-associated medium chain fatty acids.
    Neuropharmacology, 2013, Volume: 69

    Topics: Animals; Anticonvulsants; Caprylates; Cell Line; Chemical and Drug Induced Liver Injury; Convulsants

2013
[STUDY OF THE INTERMEDIATE METABOLISM OF DRUGS USING PARTIAL HEPATECTOMY].
    Kiserletes orvostudomany, 1963, Volume: 15

    Topics: Barbiturates; Caffeine; Chemical and Drug Induced Liver Injury; Chloralose; Hepatectomy; Hepatitis;

1963